IL-4-independent pathways exacerbate methacholine-induced airway hyperreactivity during mycoplasma respiratory

Matthew D Woolard1, R Doug Hardy, Jerry W Simecka

  • 1Department of Molecular Biology and Immunology, University of North Texas Health Science, Center, Fort Worth, TX 76107, USA.

Abstract

Insights

Interleukin-4 (IL-4) does not worsen airway hyperresponsiveness (AHR) in mice infected with Mycoplasma pulmonis. Instead, IL-4-independent pathways drive AHR and airway obstruction in this respiratory infection model.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Microbiology

Background:

  • Mycoplasma respiratory infections are linked to wheezing and worsened airway hyperresponsiveness (AHR) in asthma.
  • Interleukin-4 (IL-4) is crucial for AHR development and airway remodeling in asthma.
  • IL-4's role in exacerbating AHR during pulmonary mycoplasma infection requires investigation.

Purpose of the Study:

  • To investigate the impact of IL-4 on the severity of methacholine-induced AHR in the context of Mycoplasma pulmonis infection.
  • To determine if IL-4 plays a role in airway obstruction associated with mycoplasma respiratory disease.

Main Methods:

  • BALB/c and IL-4 knockout (KO) mice were infected with Mycoplasma pulmonis.
  • Whole-body plethysmography was used to measure enhanced pause scores before and after methacholine inhalation.
  • Lung histopathology was assessed in both infected and uninfected mice.

Main Results:

  • Mycoplasma pulmonis infection increased airway obstruction in both BALB/c and IL-4 KO mice, with no strain-specific difference in airway resistance.
  • IL-4 KO mice exhibited significantly higher methacholine-induced AHR post-infection compared to BALB/c mice.
  • No significant difference in AHR was observed between uninfected IL-4 KO and control mice.

Conclusions:

  • Contrary to the initial hypothesis, IL-4-independent pathways are responsible for exacerbating methacholine-induced AHR during Mycoplasma pulmonis infection.
  • These findings suggest that other mechanisms contribute to airway obstruction in mycoplasma-induced respiratory disease.
  • The study highlights the complexity of AHR regulation in respiratory infections beyond the IL-4 pathway.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...